Monte Rosa Therapeutics Inc (GLUE)

6.91 +0.40 (+6.14%) USD  |  NASDAQ  |  Dec 20, 16:00
6.915 0.00 (0.00%) After-Hours: 20:00
More

Monte Rosa Therapeutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Ratios (EV) Definition

View Enterprise Value Ratios (EV) Definition
Start Trial

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
Novartis AG Upgrade
MEI Pharma Inc Upgrade
Evoke Pharma Inc Upgrade
Revance Therapeutics Inc Upgrade
Vera Therapeutics Inc --

EV to Assets (Quarterly) Related Metrics

EV to Free Cash Flow Upgrade